Cécile Magis-Escurra

A Dose-Ranging Trial to Optimize the Dose of Rifampin in the Treatment of Tuberculosis

Martin J. Boeree, Andreas H. Diacon, Rodney Dawson et al. · American Journal of Respiratory and Critical Care Medicine · 2015 · 317 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +13

Surveillance of adverse events in the treatment of drug-resistant tuberculosis: first global report

Borisov Se, Edvardas Danila, Andrei Maryandyshev et al. · European Respiratory Journal · 2019 · 177 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Identification of biomarkers for tuberculosis disease using a novel dual-color RT–MLPA assay

Simone A. Joosten, Jelle J. Goeman, Jayne S. Sutherland et al. · Genes and Immunity · 2011 · 103 citations

Medicine, Molecular Biology, Molecular Medicine +14

Multidrug-Resistant Tuberculosis in Europe, 2010–2011

Gunar Günther, Frank van Leth, Sofia Alexandru et al. · Emerging infectious diseases · 2015 · 102 citations · Full text

Public Health, Pharmacology, Pharmacotherapy +17

Population pharmacokinetics and limited sampling strategy for first-line tuberculosis drugs and moxifloxacin

Cécile Magis-Escurra, H.M.J. Later-Nijland, Jan‐Willem C. Alffenaar et al. · International Journal of Antimicrobial Agents · 2014 · 86 citations

Pharmacy, Pharmacokinetics, Pharmacology +11